Pergola, C. Et Al. 2014. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). British Journal of Pharmacology , vol.171, no.12 , 3051-3064.

Pergola, C., Gerstmeier, J., Moench, B., Caliskan, B., Luderer, S., Weinigel, C., ... Barz, D.(2014). The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). British Journal of Pharmacology , vol.171, no.12, 3051-3064.

Pergola, C. Et Al. "The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP)," British Journal of Pharmacology , vol.171, no.12, 3051-3064, 2014

Pergola, C. Et Al. "The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP)." British Journal of Pharmacology , vol.171, no.12, pp.3051-3064, 2014

Pergola, C. Et Al. (2014) . "The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP)." British Journal of Pharmacology , vol.171, no.12, pp.3051-3064.

@article{article, author={C. Pergola Et Al. }, title={The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP)}, journal={British Journal of Pharmacology}, year=2014, pages={3051-3064} }